MiR-296-3p promotes the development and progression of preeclampsia via targeting the CEMIP

Eur Rev Med Pharmacol Sci. 2021 Jun;25(11):3938-3946. doi: 10.26355/eurrev_202106_26034.

Abstract

Objective: Preeclampsia (PE) is one of common pregnancy diseases, which has seriously threatened the health of the gravidas. Although upregulated miR-269-3p has been found in the placentas of the patients with PE, the regulation mechanisms of miR-296-3p remain unclear.

Patients and methods: In this study, the placentas of the patients and normal gravidas were used to observe the difference in miR-296-3p expression level, and HTR-8/Svneo and JAR cells were used to investigate the role of miR296-3p in trophoblast cells. Besides, qRT-PCR, Western blot, CCK-8 assay, Dual-Luciferase reporter gene assay and transwell assay were used to explore the functions and regulation mechanisms of miR-296-3p on PE.

Results: The results showed that miR-296-3p was upregulated in the PE-placentas, and increased miR-296-3p could inhibit the proliferation, invasion and migration of HTR-8/Svneo and JAR cells. Besides, miR-296-3p could directly target the 3'-UTR of CEMIP, and the phenomena induced by increased miR-296-3p, including decreased β-catenin and p-AKT and weakened proliferation, invasion and migration abilities, could be reversed by upregulating the expression level of CEMIP.

Conclusions: To summarize, this study suggests that miR-296-3p inactivates the Wnt/β-catenin and PI3K/AKT pathways to promote the progression of PE via targeting the CEMIP.

MeSH terms

  • Cell Line
  • Cell Movement
  • Cell Proliferation
  • Disease Progression
  • Female
  • Humans
  • Hyaluronoglucosaminidase / genetics*
  • MicroRNAs*
  • Placenta / metabolism
  • Pre-Eclampsia / genetics*
  • Pre-Eclampsia / metabolism
  • Pregnancy
  • Proto-Oncogene Proteins c-akt / metabolism
  • Up-Regulation
  • beta Catenin / metabolism

Substances

  • CTNNB1 protein, human
  • MIRN296 microRNA, human
  • MicroRNAs
  • beta Catenin
  • Proto-Oncogene Proteins c-akt
  • CEMIP protein, human
  • Hyaluronoglucosaminidase